Venlar Labs Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 23-06-2024
- Paid Up Capital ₹ 1.81 Cr
as on 23-06-2024
- Company Age 22 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 17.22 Cr
as on 23-06-2024
- Revenue %
(FY 2020)
- Profit 62.78%
(FY 2020)
- Ebitda 63.51%
(FY 2020)
- Net Worth -0.08%
(FY 2020)
- Total Assets -6.43%
(FY 2020)
About Venlar Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.81 Cr.
The company has closed loans amounting to ₹17.22 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Enugala Reddy and Rajashekar Mesineni serve as directors at the Company.
- CIN/LLPIN
U24239TG2002PTC038746
- Company No.
038746
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Apr 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Venlar Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Enugala Reddy  | Additional Director | 20-Apr-2022 | Current |
| Rajashekar Mesineni | Director | 02-Jan-2003 | Current |
Financial Performance of Venlar Labs.
Venlar Labs Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 62.78% increase in profit. The company's net worth dipped by a decrease of 0.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venlar Labs?
In 2019, Venlar Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Venkar Chemicals Private LimitedActive 25 years 10 monthsEnugala Reddy and Rajashekar Mesineni are mutual person
Vtides Lifesciences Private LimitedActive 10 months 8 daysEnugala Reddy and Rajashekar Mesineni are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Small Industries Development Bank Of India Creation Date: 29 Sep 2011 | ₹3.80 M | Satisfied |
State Bank Of India Creation Date: 05 May 2011 | ₹13.19 Cr | Satisfied |
State Bank Of India Creation Date: 06 Nov 2008 | ₹3.00 Cr | Satisfied |
How Many Employees Work at Venlar Labs?
Venlar Labs has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venlar Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venlar Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
